Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.
Zhu B, Wei X, Narasimhan H, Qian W, Zhang R, Cheon IS, Wu Y, Li C, Jones RG, Kaplan MH, Vassallo RA, Braciale TJ, Somerville L, Colca JR, Pandey A, Jackson PEH, Mann BJ, Krawczyk CM, Sturek JM, Sun J. Zhu B, et al. Among authors: jackson peh. Sci Immunol. 2023 Apr 14;8(82):eadf0348. doi: 10.1126/sciimmunol.adf0348. Epub 2023 Apr 14. Sci Immunol. 2023. PMID: 36821695 Free PMC article.
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.
Sasson J, Donlan AN, Ma JZ, Haughey HM, Coleman R, Nayak U, Mathers AJ, Laverdure S, Dewar R, Jackson PEH, Heysell SK, Sturek JM, Petri WA Jr. Sasson J, et al. Among authors: jackson peh. medRxiv [Preprint]. 2022 May 19:2022.03.30.22273194. doi: 10.1101/2022.03.30.22273194. medRxiv. 2022. PMID: 35411349 Free PMC article. Updated. Preprint.
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial.
Sasson J, Donlan AN, Ma JZ, Haughey HM, Coleman R, Nayak U, Mathers AJ, Laverdure S, Dewar R, Jackson PEH, Heysell SK, Sturek JM, Petri WA Jr. Sasson J, et al. Among authors: jackson peh. Open Forum Infect Dis. 2022 Jul 27;9(8):ofac343. doi: 10.1093/ofid/ofac343. eCollection 2022 Aug. Open Forum Infect Dis. 2022. PMID: 35959207 Free PMC article.
Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial.
Hendrick J, Ma JZ, Haughey HM, Coleman R, Nayak U, Kadl A, Sturek JM, Jackson P, Young MK, Allen JE, Petri WA. Hendrick J, et al. Open Forum Infect Dis. 2024 Jan 3;11(2):ofad630. doi: 10.1093/ofid/ofad630. eCollection 2024 Feb. Open Forum Infect Dis. 2024. PMID: 38312212 Free PMC article. Clinical Trial.
Analysis of National Institutes of Health Funding for the COVID-19 Pandemic.
Narahari AK, Horgan TM, Chandrabhatla AS, Gist DC, Patel PD, Lantieri MA, Sturek JM, Davis CL, Jackson PEH, Bell TD. Narahari AK, et al. Among authors: jackson peh. Open Forum Infect Dis. 2024 Mar 26;11(3):ofae064. doi: 10.1093/ofid/ofae064. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38533269 Free PMC article. Clinical Trial.
22 results